Featuring 9 tracks of programming, the MIXiii BIOMED 2020 Conference invites attendees to explore what’s next in the worlds of Biotechnology and Life Sciences.
18th National Life Sciences & Technology Week
May 15 – 17, 2019 | David InterContinental Tel Aviv, Israel
17th National Life Sciences & Technology Week
May 15 – 17, 2018 | David InterContinental Tel Aviv, Israel
16th National Life Science & Technology Week
Robert Cohen
VP of Global R&D, Chief Technology Officer, Stryker Joint Replacement
Amy Schulman
Managing Partner, Polaris Partners
Prof. Robert Langer
Institute Professor at MIT, MIT Department of Chemical Engineering
Andrew “Cal” Callaway
Managing Director, U.S. Healthcare Investment Banking, Royal Bank of Canada (RBC)
Prof. Yitshak Kreiss, MD
Director General, Sheba Medical Center
Aharon Aharon
CEO, Israel Innovation Authority (IIA)
Eric H. Rubin MD
Senior VP, Global Clinical Oncology, Merck & Co
Jeremy M. Levin MD
CEO and Chairman, Ovid Therapeutics
Targeted Cancer Treatment; Cure? Maintenance? – Has Medicine Reached these Points?
Chair: Prof. David Sidransky, MD,
Johns Hopkins School of Medicine; Co-Founder & General Partner, Israel Biotech Fund
Decoding the Brain Enigma: Parkinson, Alzheimer’s, ALS, Mental Disorders
Co-Chairs: Barry Greene
President, Alnylam Pharmaceuticals
Dekel Taliaz, PhD
Co-Founder and CEO, Taliaz
AI Technology Redefining the Future of Biopharma, Care Delivery, and Holistic Medicine
Co-Chairs: Iris Grossman, PhD
Chief Scientific Officer, Camp4 Therapeutics
Tamara Mansfeld
Global Innovation Lead, Digital Innovation Lab, Pfizer
Next Generation BioTherapeutics – Gene Editing, RNAi, Oligos, Cell and Gene Therapies and others
Co-Chairs: Yaron Carmi, PhD
Assistant Professor, Sackler School of Medicine, Tel Aviv University
Jonathan Solomon
CEO, BiomX
Bright Spots Illuminating the Future of Medical Devices
Co-chairs: Irit Yaniv, MD
Managing Partner, Accelmed Ventures Fund
James Eadie, MD
Partner, Santé Ventures
Exact and Biological Science Diagnostics – Sensors, Genomics, AI, Imaging, and others
Co-Chairs: Prof. Varda Shalev, MD, MPA
Head, KSM Kahn – Sagol – Maccabi Research & Innovation Institute
Yair Schindel, MD
Managing Partner & Co-Founder, aMoon Fund
Robotics Role in Future Healthcare Systems
Chair: Ori Hadomi
VP New Business Development & Partnerships, Medtronic
Aging Science and Technology – From Single Cell to Population at Large
Co-Chairs: Anat Naschitz
Managing Director, OrbiMed Advisors
Yael Benvenisti, PhD
CEO, Mediterranean Towers Ventures
Bio-convergence – Biologically Inspired Engineering Reshaping Future Medicine
Federico Goodsaid, PhD
Ex-FDA & Senior VP Regulatory Affairs, Ariana Pharma
Dimitris Agrafiotis, PhD
Chief Information Officer, Novartis Institutes for BioMedical Research (NIBR)
Rosana Kapeller-Libermann, PhD
EIR, Google Ventures
Daphna Laifenfeld, PhD
Chief Strategy Officer, Ibex Medical Analytics
Michal Ozery-Flato, PhD
Machine Learning Researcher, IBM Research
Eric de La Fortelle, PhD
Venture Partner, Seventure
Pierre Belichard
CEO, Enterome
Jeremy M. Levin MD
CEO and Chairman, Ovid Therapeutics
Dimitrios Arkilo, MD
Sr. Medical Director, Global Clinical Lead. Takeda Pharmaceutical Co
Prof. Amir Lerman, MD
Cardiovascular Diseases and Internal Medicine, Mayo Clinic
Prof. Tamar Flash, PhD
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science
Wenbo Liu
Sinovation (Beijing) Medical Technology Co., LTD
Allitia DiBernardo, MD
Global Medical Affairs Lead, Neurosciences, The Janssen Pharmaceutical Companies of Johnson & Johnson
Prof. Peter A. Noseworthy, MD
Department of Cardiovascular Medicine
Mayo Clinic
Miro Venturi, PhD
Global Head – Diagnostics Biomarkers
F. Hoffmann-La Roche Ltd.
Barry Greene
President, Alnylam Pharmaceuticals
Tom Sudow
Director Business Development, Cleveland Clinic Innovations
The conference serves as a meeting point for local and multinational companies, venture capitalists, private equity investors, corporate and institutional investors, technology transfer experts, licensing executives, business development executives, university, government and corporate research scientists and government representatives.
